BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37371581)

  • 1. OTUD7B Activates Wnt Signaling Pathway through the Interaction with LEF1.
    Lee Y; Piao HL; Kim J
    Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of LEF1 by MYC activates the WNT pathway and maintains cell proliferation.
    Hao YH; Lafita-Navarro MC; Zacharias L; Borenstein-Auerbach N; Kim M; Barnes S; Kim J; Shay J; DeBerardinis RJ; Conacci-Sorrell M
    Cell Commun Signal; 2019 Oct; 17(1):129. PubMed ID: 31623618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte nuclear factor 1β suppresses canonical Wnt signaling through transcriptional repression of lymphoid enhancer-binding factor 1.
    Chan SC; Hajarnis SS; Vrba SM; Patel V; Igarashi P
    J Biol Chem; 2020 Dec; 295(51):17560-17572. PubMed ID: 33453998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The osteogenic differentiation of human adipose-derived stem cells is regulated through the let-7i-3p/LEF1/β-catenin axis under cyclic strain.
    Luo Y; Ge R; Wu H; Ding X; Song H; Ji H; Li M; Ma Y; Li S; Wang C; Du H
    Stem Cell Res Ther; 2019 Nov; 10(1):339. PubMed ID: 31753039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ERG is a critical regulator of Wnt/LEF1 signaling in prostate cancer.
    Wu L; Zhao JC; Kim J; Jin HJ; Wang CY; Yu J
    Cancer Res; 2013 Oct; 73(19):6068-79. PubMed ID: 23913826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA LEF1-AS1/LEF1/FUT8 Axis Mediates Colorectal Cancer Progression by Regulating α1, 6-Fucosylationvia Wnt/β-Catenin Pathway.
    Qi Y; Shan Y; Li S; Huang Y; Guo Y; Huang T; Zhao X; Jia L
    Dig Dis Sci; 2022 Jun; 67(6):2182-2194. PubMed ID: 34021424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PARsylated transcription factor EB (TFEB) regulates the expression of a subset of Wnt target genes by forming a complex with β-catenin-TCF/LEF1.
    Kim S; Song G; Lee T; Kim M; Kim J; Kwon H; Kim J; Jeong W; Lee U; Na C; Kang S; Kim W; Seong JK; Jho EH
    Cell Death Differ; 2021 Sep; 28(9):2555-2570. PubMed ID: 33753903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lef1 contributes to the differentiation of bulge stem cells by nuclear translocation and cross-talk with the Notch signaling pathway.
    Zhang Y; Yu J; Shi C; Huang Y; Wang Y; Yang T; Yang J
    Int J Med Sci; 2013; 10(6):738-46. PubMed ID: 23630438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SNAIL1 employs β-Catenin-LEF1 complexes to control colorectal cancer cell invasion and proliferation.
    Freihen V; Rönsch K; Mastroianni J; Frey P; Rose K; Boerries M; Zeiser R; Busch H; Hecht A
    Int J Cancer; 2020 Apr; 146(8):2229-2242. PubMed ID: 31463973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-621 functions as a metastasis suppressor in colorectal cancer by directly targeting LEF1 and suppressing Wnt/β-catenin signaling.
    Chen X; Tu J; Liu C; Wang L; Yuan X
    Life Sci; 2022 Nov; 308():120941. PubMed ID: 36087740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-Catenin-independent activation of TCF1/LEF1 in human hematopoietic tumor cells through interaction with ATF2 transcription factors.
    Grumolato L; Liu G; Haremaki T; Mungamuri SK; Mong P; Akiri G; Lopez-Bergami P; Arita A; Anouar Y; Mlodzik M; Ronai ZA; Brody J; Weinstein DC; Aaronson SA
    PLoS Genet; 2013; 9(8):e1003603. PubMed ID: 23966864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigations on the mechanism of progesterone in inhibiting endometrial cancer cell cycle and viability via regulation of long noncoding RNA NEAT1/microRNA-146b-5p mediated Wnt/β-catenin signaling.
    Huang X; Zhong R; He X; Deng Q; Peng X; Li J; Luo X
    IUBMB Life; 2019 Feb; 71(2):223-234. PubMed ID: 30452118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-Catenin/LEF1 transactivates the microRNA-371-373 cluster that modulates the Wnt/β-catenin-signaling pathway.
    Zhou AD; Diao LT; Xu H; Xiao ZD; Li JH; Zhou H; Qu LH
    Oncogene; 2012 Jun; 31(24):2968-78. PubMed ID: 22020335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte growth factor activates Wnt pathway by transcriptional activation of LEF1 to facilitate tumor invasion.
    Huang FI; Chen YL; Chang CN; Yuan RH; Jeng YM
    Carcinogenesis; 2012 Jun; 33(6):1142-8. PubMed ID: 22436613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizations of a novel fluorescence polarization-based high-throughput screening assay for β-catenin/LEF1 interaction inhibitors.
    Chen Y; Fu Z; Li D; Yue Y; Liu X
    Anal Biochem; 2021 Jan; 612():113966. PubMed ID: 32956692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repression of WT1-Mediated LEF1 Transcription by Mangiferin Governs β-Catenin-Independent Wnt Signalling Inactivation in Hepatocellular Carcinoma.
    Tan HY; Wang N; Li S; Hong M; Guo W; Man K; Cheng CS; Chen Z; Feng Y
    Cell Physiol Biochem; 2018; 47(5):1819-1834. PubMed ID: 29953980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cinobufagin Suppresses Melanoma Cell Growth by Inhibiting LEF1.
    Kim GH; Fang XQ; Lim WJ; Park J; Kang TB; Kim JH; Lim JH
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32933177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The transcription factor Lef1 switches partners from β-catenin to Smad3 during muscle stem cell quiescence.
    Aloysius A; DasGupta R; Dhawan J
    Sci Signal; 2018 Jul; 11(540):. PubMed ID: 30042129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.
    Nguyen A; Rosner A; Milovanovic T; Hope C; Planutis K; Saha B; Chaiwun B; Lin F; Imam SA; Marsh JL; Holcombe RF
    Int J Oncol; 2005 Oct; 27(4):949-56. PubMed ID: 16142310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficient LEF1 expression is associated with lithium resistance and hyperexcitability in neurons derived from bipolar disorder patients.
    Santos R; Linker SB; Stern S; Mendes APD; Shokhirev MN; Erikson G; Randolph-Moore L; Racha V; Kim Y; Kelsoe JR; Bang AG; Alda M; Marchetto MC; Gage FH
    Mol Psychiatry; 2021 Jun; 26(6):2440-2456. PubMed ID: 33398088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.